- Home
- MARPS vs PRPO Comparison
MARPS vs PRPO Comparison
Compare MARPS & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- PRPO
- Stock Information
- Founded
- MARPS 1956
- PRPO N/A
- Country
- MARPS United States
- PRPO United States
- Employees
- MARPS N/A
- PRPO N/A
- Industry
- MARPS Oil & Gas Production
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- MARPS Energy
- PRPO Industrials
- Exchange
- MARPS Nasdaq
- PRPO Nasdaq
- Market Cap
- MARPS 7.9M
- PRPO 9.5M
- IPO Year
- MARPS N/A
- PRPO N/A
- Fundamental
- Price
- MARPS $3.85
- PRPO $6.25
- Analyst Decision
- MARPS
- PRPO
- Analyst Count
- MARPS 0
- PRPO 0
- Target Price
- MARPS N/A
- PRPO N/A
- AVG Volume (30 Days)
- MARPS 8.4K
- PRPO 7.5K
- Earning Date
- MARPS 01-01-0001
- PRPO 11-06-2024
- Dividend Yield
- MARPS 8.71%
- PRPO N/A
- EPS Growth
- MARPS N/A
- PRPO N/A
- EPS
- MARPS 0.36
- PRPO N/A
- Revenue
- MARPS $1,042,513.00
- PRPO $17,411,000.00
- Revenue This Year
- MARPS N/A
- PRPO $75.18
- Revenue Next Year
- MARPS N/A
- PRPO N/A
- P/E Ratio
- MARPS $10.88
- PRPO N/A
- Revenue Growth
- MARPS N/A
- PRPO 31.31
- 52 Week Low
- MARPS $3.77
- PRPO $4.31
- 52 Week High
- MARPS $6.50
- PRPO $8.49
- Technical
- Relative Strength Index (RSI)
- MARPS 39.36
- PRPO 52.41
- Support Level
- MARPS $3.92
- PRPO $6.14
- Resistance Level
- MARPS $4.09
- PRPO $6.47
- Average True Range (ATR)
- MARPS 0.11
- PRPO 0.19
- MACD
- MARPS -0.02
- PRPO 0.01
- Stochastic Oscillator
- MARPS 0.00
- PRPO 88.00
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.